Robert Mendez

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

A. Osama Gaber, M. Roy First, Raymond J. Tesi et al. · Transplantation · 1998 · 301 citations

Life Sciences, Immunology, Nephrology +17

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

Marc I. Lorber, Shamkant Mulgaonkar, Khalid M.H. Butt et al. · Transplantation · 2005 · 232 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATION

David A. Laskow, Flavio Vincenti, John F. Neylan et al. · Transplantation · 1996 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +15

Single-cell chromatin accessibility identifies pancreatic islet cell type– and state-specific regulatory programs of diabetes risk

Joshua Chiou, Chun Zeng, Cheng Zhang et al. · Nature Genetics · 2021 · 191 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

Thomas A. Gonwa, Robert Mendez, Harold C. Yang et al. · Transplantation · 2003 · 188 citations

Medicine, Nephrology, Pharmacotherapy +17